UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO - VIR BIOTECHNOLOGY INC ownership

VIR BIOTECHNOLOGY INC's ticker is VIR and the CUSIP is 92764N102. A total of 167 filers reported holding VIR BIOTECHNOLOGY INC in Q2 2021. The put-call ratio across all filers is 0.78 and the average weighting 0.3%.

Quarter-by-quarter ownership
UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO ownership history of VIR BIOTECHNOLOGY INC
ValueSharesWeighting
Q3 2022$2,514,000
-79.3%
130,409
-55.1%
0.94%
-83.0%
Q4 2021$12,173,000
+151.2%
290,736
+207.6%
5.53%
+94.4%
Q1 2021$4,846,00094,5132.84%
Other shareholders
VIR BIOTECHNOLOGY INC shareholders Q2 2021
NameSharesValueWeighting ↓
Bill & Melinda Gates Foundation 1,559,142$39,700,00030.52%
SB INVESTMENT ADVISERS (UK) LTD 22,216,644$565,858,0004.50%
Zebra Capital Management LLC 25,419$647,0001.90%
Alaska Permanent Fund Corp 2,300,000$58,581,0000.84%
CLARK ESTATES INC/NY 180,000$4,585,0000.79%
Temasek Holdings (Private) Ltd 5,602,553$142,697,0250.78%
SECTOR GAMMA AS 110,223$2,807,0000.63%
Avidity Partners Management LP 758,211$19,312,0000.44%
New Vernon Capital Holdings II LLC 14,501$369,0000.30%
DUALITY ADVISERS, LP 116,415$2,965,0000.29%
View complete list of VIR BIOTECHNOLOGY INC shareholders